Catalyst Wire Dossier Catalyst Wire Dossier

Andecaliximab

· Ashibio Inc
Drug timelines are a Plus or Pro feature.

11 regulatory and trial events tracked for Andecaliximab, covering 2018-06-27 to 2025-10-14. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Andecaliximab in Participants With Fibrodysplasia Ossificans Progressiva (FOP) [Phase 2, Phase 3]

See pricing